Document is current
Any future updates will be listed below
-
Authors
Adami, Giovanni https://orcid.org/0000-0002-8915-0755
Rossini, Maurizio https://orcid.org/0000-0001-9692-2293
Viapiana, Ombretta https://orcid.org/0000-0003-1917-5655
- License Information
-
More Information
Article History
Received: 30 June 2025
Accepted: 6 November 2025
First Online: 19 November 2025
Change Date: 26 January 2026
Change Type: Update
Change Details: The original version of this article has been updated due to retrospective open access.
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Giovanni Adami reports speaker and consultant fees from Galapagos, Theramex, Amgen, Eli-Lilly, UCB, Fresenius Kabi, BMS, Abiogen and Pfizer. Maurizio Rossini received speaker and consultant fees from Theramex, Eli-Lilly, Abbvie, Italfarmaco, Neopharmed-Gentili and Janssen-Cilag. Ombretta Viapiana reports speaker and consultant fees from Eli-Lilly, Abbvie, Angelini, Grunenthal, Amgen, UCB and Fresenius Kabi.
